The scientist will produce anticancer drugs by cloning the egg
The research institute of Rosling of Edinburg of Scotland that once cloned many jasmines of sheep announces recently, they plan to produce anticancer drug in enormous quantities with the egg improved through heredity. It is said, the new project of this research institute is to plan to produce and contain the egg that can treat the protein antibody of skin carcinoma within one year. The scientists plan to cultivate the hen with special gene first, contain protein needed to prepare various anticancer drug in the egg egg white making them give birth to, then clone these hens. This project is carried on by cooperating with biotech company Viragen of U.S.A., and the first batch of genes that this company will offer soon will be produced and will be used for treating the black plain tumour - --Antibody of skin carcinoma. Some research that is carried on subsequently will also involve other albumen medicines, used for including other cancers such as lung cancer and intestinal cancer in treatment. A lot of anticancer drug such as interferon is based on protein at present, because molecular structure is complicated and difficult to produce in enormous quantities, so is very expensive and rare. In addition, though produce the milk with antibody albumen through the way that the law of genetic engineering can cultivate animals such as the ox, sheep and rabbit,etc., but Viragen Company think with clone the intersection of egg and law, come, it produces anticancer drug to be can faster and cheaper still. It is estimated, each transgenic hen can produce 250 eggs in one year at present, contain protein used for medicine in each egg. (Cao ShuFen)
|
0 comments:
Post a Comment